This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Stocks in play: HLS Therapeutics Inc.
Will release its Q3 fiscal 2024 financial results on Thursday, November 7. The Company will hold a conference call that same day at 8:30 a.m. ET to discuss its results. HLS Therapeutics Inc. shares T.HLS are trading unchanged at $3.87.
